All stories by Sohini Das
Why Covishield Production Has Resumed
Rediff.com20 Apr 2023'I understand some people are comfortable getting a Covishield shot as their third dose.'
Amid Covid surge, the reality: Fewer vaccination centres
Rediff.com10 Apr 2023Serum Institute of India (SII) and Bharat Biotech have also stopped producing the Covishield and Covaxin vaccines respectively.
Chip shortage may derail automakers FY24 production plans
Rediff.com4 Apr 2023Even as India's passenger-vehicle sales touched a record high of 3.9 million units in 2022-23, growing 27 per cent over the previous financial year, the country's largest carmaker, Maruti Suzuki India (MSIL), said on Monday uncertainties in the electronic-component supplies might affect production in FY24. MSIL said the shortage of electronic components had some impact on production in FY23. "The company took all possible measures to minimise the impact.
Check Blood Glucose Levels Minus Prick
Rediff.com21 Mar 2023One needs to charge the device every four days, which can provide over 65,000 blood readings and counts.
Maruti Sold 584,126 Cars In Rural Markets
Rediff.com6 Mar 2023Maruti Suzuki says it has sold at least one car in 418,000 villages.
With 33% market share, Maruti eyes top slot in SUV space by FY24
Rediff.com16 Feb 2023Maruti Suzuki India (MSIL) - the market leader in small cars - is eyeing the top spot in the sports utility vehicle (SUV) segment within a year - with a 33 per cent share of the pie. The company has been selling two SUVs - the Brezza and the Grand Vitara - and will start deliveries of the Jimny and the Fronx from March-end, and has set a target of growing its share from the current 11.5 per cent of the SUV market to 33 per cent by the end of 2023-24. The SUV segment is roughly about 42 per cent of the total passenger vehicle market, or around 1.3 million units.
'A creative mind never ages'
Rediff.com26 Jan 2023Balkrishna V Doshi, who won the Pritzker Award in 2018 -- which is equivalent to the Nobel Prize in architecture -- passed into the ages this week. Sohini Das recalls an encounter with the the legendary architect, who was posthumously awarded the Padma Vibhushan in this year's Republic Day honours list.
More Women Buy Luxury Cars In Post-pandemic Shift
Rediff.com26 Jan 2023Dealerships, too, are going all out to roll out the red carpet for women.
'None of the existing vaccines can prevent emerging variants of Omicron'
Rediff.com25 Jan 2023'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'
Marginal rise in people opting for e-vehicles, finds survey
Rediff.com24 Jan 2023The top reason drawing consumers to EVs is lower fuel cost.
Bajaj's e-Chetak to speed into Europe by 2024
Rediff.com21 Jan 2023The electric Chetak has already sold close to 25,000 units in India, and the European version will be based on the same platform.
Why luxury carmakers will see quicker transition to EVs
Rediff.com19 Jan 2023While Mercedes-Benz India expects 25 per cent of its India sales to come from EVs in the next four years, BMW says it estimates around 10 per cent of sales to come from those in the near future.
Field testing started for fuel-agnostic engines
Rediff.com19 Jan 2023Cummins India will soon start producing fuel-agnostic engine systems at the Tata-Cummins plant in Phaltan in Satara district of Maharashtra, senior officials at Cummins India said. The firm will start limited production by the end of 2023 and mass production will likely begin by 2024, the officials said.
India 'Stay Calm' About Kraken: Experts
Rediff.com16 Jan 2023The Kraken COVID-19 variant accounts for almost 41 per cent of all Covid infections.
Kinetic to start producing electric version of Luna at Ahmednagar plant
Rediff.com27 Dec 2022Kinetic Engineering (KEL), the makers of the iconic Luna two-wheelers in the seventies, will soon start producing components for an electric version of the moped. Pune-based Kinetic said in September that Luna would make a comeback in an electric avatar. The electric Luna, or E-Luna, will be launched by KEL's sister company Kinetic Green Energy and Power Solutions.
New Covid strains may lead to spike in hospitalisation, fear experts
Rediff.com27 Oct 2022An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.
Why Govt Wants To Ban These Cough Meds
Rediff.com17 Oct 2022Codeine-based formulations are under the scanner for misuse as a narcotic product.
Now, medical device resellers need to register
Rediff.com5 Oct 2022The Centre has asked traders and resellers of medical devices to register in an attempt to expand the ambit of regulating the medical devices industry in the country. The move can have far-reaching consequences for both consumers and traders alike as products like face masks or prophylactics - now sold through grocers and other channels - may face issues of availability. In a notification dated September 30, the union ministry of health and family welfare said anyone wanting to sell, stock, exhibit or offer for sale or distribute a medical device, including in-vitro diagnostic medical device, will need a certificate of registration.
Hard choice for MSME med device makers: Get licence by Oct 1 or shut shop
Rediff.com27 Sep 2022The transition of Class A and Class B medical device makers to the licensing regime by October 1 seems to be an uphill task with several small and medium manufacturers saying they are still awaiting the audit from the government authorities. If the licenses don't come through, either due to lack of audits or MSME units not clearing the audits, then a few thousand small-scale medical device units will face the issue of business continuity in three weeks. Class A medical devices are those with low to moderate risk to the patient or user (surgical dressings for example), while Class B medical devices refer to devices with moderate risks that require special controls (catheters for example).
Ni-kshay Mitra: Crowdfunding To Fight TB
Rediff.com17 Sep 2022This would be India's largest crowd-funded programme to help patients with a particular disease.